Ian Schwartz is Sartorius Stedim Biotech’s global bioconjugate technology consultant and advises bioconjugate companies around the world on process development, technology transfer and manufacturing scale up. He joined Sartorius in 2016 and has over 15 years of experience in the biopharmaceutical industry.
Ian received his Bachelor and Master of Science from the University of Rochester (NY, USA) in Biomedical Engineering and began his career at Biogen (MA, USA) in the Protein Chemistry department. He moved onto positions of increasing responsibility at ImmunoGen (MA, USA), MedImmune (MD, USA) and most recently Agensy, a former affiliate of Astellas Pharmaceuticals, where he started up and led ADC process development, tech transfer, and manufacturing support for a number of years before joining sartorius in 2016.
Ian is a regularly invited speaker and chair-person at ADC conferences and frequent judge for World ADC awards.